Literature DB >> 18478177

Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.

Martin Marziniak1, Anna Laura Herzog, Andrea Herzog, Rainald Mössner, Claudia Sommer.   

Abstract

Experimental studies and investigations of the cerebrospinal fluid in migraineurs have suggested an involvement of brain-derived neurotrophic factor (BDNF) in migraine pathophysiology. In a case-control study approach, the functional Val66MET polymorphism (rs6265) of the BDNF gene was investigated in 265 migraine patients and 153 controls. Genotype and allele frequencies did not differ between healthy subjects and migraineurs. A subgroup analysis for the occurrence of aura or clinical characteristics, including the number of attacks, did not reveal a positive association for the investigated polymorphism. Our data argue against a role of this well characterized BDNF gene variant as a risk factor in migraine.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18478177     DOI： 10.1007/s00702-008-0056-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  23 in total

1.  A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression.

Authors:  Srijan Sen; Randolph M Nesse; Scott F Stoltenberg; Sheng Li; Lillian Gleiberman; Aravinda Chakravarti; Alan B Weder; Margit Burmeister
Journal:  Neuropsychopharmacology       Date:  2002-08-29       Impact factor: 7.853

2.  Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1.

Authors:  P C Suen; K Wu; E S Levine; H T Mount; J L Xu; S Y Lin; I B Black
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

Authors:  Mònica Gratacòs; Juan R González; Josep M Mercader; Rafael de Cid; Mikel Urretavizcaya; Xavier Estivill
Journal:  Biol Psychiatry       Date:  2007-01-09       Impact factor: 13.382

4.  Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.

Authors:  Ilya Buldyrev; Nathan M Tanner; Hui-ya Hsieh; Emily G Dodd; Loi T Nguyen; Agnieszka Balkowiec
Journal:  J Neurochem       Date:  2006-10-25       Impact factor: 5.372

Review 5.  Neurotrophins: mediators and modulators of pain.

Authors:  Sophie Pezet; Stephen B McMahon
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

Review 6.  Nerve growth factor and chronic daily headache: a potential implication for therapy.

Authors:  Paola Sarchielli; Virgilio Gallai
Journal:  Expert Rev Neurother       Date:  2004-01       Impact factor: 4.618

7.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

8.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

9.  Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.

Authors:  P C Maisonpierre; L Belluscio; S Squinto; N Y Ip; M E Furth; R M Lindsay; G D Yancopoulos
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

10.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.

Authors:  L A Mamounas; M E Blue; J A Siuciak; C A Altar
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167
View more
  5 in total

1.  Contribution of COMT and BDNF Genotype and Expression to the Risk of Transition From Acute to Chronic Low Back Pain.

Authors:  Kyle M Baumbauer; Divya Ramesh; Mallory Perry; Katherine B Carney; Thomas Julian; Nicole Glidden; Susan G Dorsey; Angela R Starkweather; Erin E Young
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

2.  Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.

Authors:  Cherubino Di Lorenzo; Giorgio Di Lorenzo; Grazia Sances; Natascia Ghiotto; Elena Guaschino; Gaetano S Grieco; Filippo M Santorelli; Carlo Casali; Alfonso Troisi; Alberto Siracusano; Francesco Pierelli
Journal:  J Headache Pain       Date:  2009-06-11       Impact factor: 7.277

3.  Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine.

Authors:  Salih Coskun; Sefer Varol; Hasan H Ozdemir; Elif Agacayak; Birsen Aydın; Oktay Kapan; Mehmet Akif Camkurt; Saban Tunc; Mehmet Ugur Cevik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-19       Impact factor: 2.570

Review 4.  Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies.

Authors:  Salvatore Terrazzino; Sarah Cargnin; Michele Viana; Grazia Sances; Cristina Tassorelli
Journal:  Front Neurol       Date:  2017-05-01       Impact factor: 4.003

Review 5.  The association between brain-derived neurotrophic factor gene polymorphism and migraine: a meta-analysis.

Authors:  Xiaoying Cai; Xiaolei Shi; Ximeng Zhang; Aiwu Zhang; Minying Zheng; Yannan Fang
Journal:  J Headache Pain       Date:  2017-02-02       Impact factor: 7.277
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.